Global pharmaceutical and biotech patent law is an ever-changing battleground, and the past twenty months only amplified existing struggles for control of increasingly competitive intellectual property rights.
In anticipation of our industry-leading 15th Anniversary Forum on Pharma & Biotech Patent Litigation in Europe this February, C5 is pleased to invite you to our complimentary webinar on European Pharma & Biotech Patent Litigation Year in Review: The Top 5 Most Critical Developments from 2021 taking place 25 January, 3 PM – 5 PM CET.
With a historic 2021 behind us, renowned thought leaders from the European life sciences patent bar will take stock of the most important developments from the past year, and offer best practices on how to manage increasing, overlapping, and uncertain risk factors.
- Sabrina Duschner, Head of Patent Litigation Strategy at Fresenius Kabi
- Dominic Adair, Partner at Bristows LLP (U.K)
- Bert Oosting, Partner at Hogan Lovells
- Ruud van der Velden, Partner at Hogan Lovells
About C5 Communications:
A unique organization, C5 Communications is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in Europe, and around the world.
Staffed by industry specialists, lawyers and other professionals, C5 Communications operates as a think-tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.